Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycosis Fungoides | 15 | 2022 | 169 | 2.980 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 14 | 2021 | 210 | 2.550 |
Why?
|
Sezary Syndrome | 10 | 2022 | 80 | 2.470 |
Why?
|
Skin Neoplasms | 23 | 2025 | 5863 | 1.440 |
Why?
|
Interleukins | 5 | 2025 | 796 | 1.310 |
Why?
|
Dermatitis, Atopic | 9 | 2021 | 737 | 1.050 |
Why?
|
Keratinocytes | 15 | 2025 | 876 | 0.990 |
Why?
|
Th2 Cells | 4 | 2025 | 1078 | 0.880 |
Why?
|
Calcitriol | 1 | 2025 | 303 | 0.850 |
Why?
|
Epidermis | 4 | 2019 | 539 | 0.820 |
Why?
|
Fluorouracil | 2 | 2025 | 1652 | 0.690 |
Why?
|
Aminoquinolines | 3 | 2017 | 105 | 0.620 |
Why?
|
Activins | 1 | 2019 | 211 | 0.590 |
Why?
|
Precancerous Conditions | 1 | 2025 | 985 | 0.590 |
Why?
|
Skin | 13 | 2024 | 4503 | 0.550 |
Why?
|
Chemokines, CXC | 1 | 2017 | 420 | 0.490 |
Why?
|
Mouth Mucosa | 1 | 2018 | 435 | 0.490 |
Why?
|
Chemokines | 1 | 2017 | 963 | 0.410 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 594 | 0.360 |
Why?
|
Up-Regulation | 5 | 2019 | 4146 | 0.350 |
Why?
|
Oxonic Acid | 1 | 2009 | 32 | 0.330 |
Why?
|
Tegafur | 1 | 2009 | 40 | 0.330 |
Why?
|
Receptors, CCR4 | 2 | 2019 | 77 | 0.300 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 3114 | 0.280 |
Why?
|
Cytokines | 6 | 2025 | 7453 | 0.270 |
Why?
|
Colitis, Ulcerative | 1 | 2018 | 1926 | 0.260 |
Why?
|
Psoriasis | 3 | 2017 | 926 | 0.240 |
Why?
|
Dermatitis | 2 | 2017 | 203 | 0.230 |
Why?
|
Galectins | 2 | 2019 | 295 | 0.230 |
Why?
|
Stomach Neoplasms | 2 | 2017 | 1481 | 0.220 |
Why?
|
Pruritus | 2 | 2017 | 379 | 0.220 |
Why?
|
Cisplatin | 1 | 2009 | 1660 | 0.210 |
Why?
|
Case-Control Studies | 12 | 2021 | 22291 | 0.200 |
Why?
|
RNA, Messenger | 9 | 2019 | 12800 | 0.200 |
Why?
|
Cyclophilin A | 1 | 2021 | 57 | 0.190 |
Why?
|
Chemokine CCL17 | 1 | 2021 | 26 | 0.190 |
Why?
|
Antigens, Neoplasm | 2 | 2022 | 1997 | 0.180 |
Why?
|
Serpins | 1 | 2022 | 246 | 0.180 |
Why?
|
Prednisolone | 2 | 2018 | 326 | 0.180 |
Why?
|
Receptors, CCR3 | 1 | 2019 | 62 | 0.170 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2892 | 0.160 |
Why?
|
Neoplasm Staging | 5 | 2020 | 11244 | 0.160 |
Why?
|
Anticarcinogenic Agents | 1 | 2021 | 251 | 0.160 |
Why?
|
4-1BB Ligand | 1 | 2018 | 29 | 0.160 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2018 | 42 | 0.160 |
Why?
|
GATA6 Transcription Factor | 1 | 2018 | 54 | 0.150 |
Why?
|
Serum Amyloid A Protein | 1 | 2018 | 128 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 53 | 0.150 |
Why?
|
Interferon Regulatory Factor-2 | 1 | 2017 | 22 | 0.150 |
Why?
|
Staphylococcal Skin Infections | 1 | 2018 | 78 | 0.150 |
Why?
|
Purpura | 1 | 2018 | 117 | 0.150 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 257 | 0.150 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2017 | 897 | 0.150 |
Why?
|
Middle Aged | 27 | 2021 | 223492 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 354 | 0.140 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5717 | 0.140 |
Why?
|
Chemokine CCL4 | 1 | 2017 | 127 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2017 | 125 | 0.140 |
Why?
|
Neovascularization, Pathologic | 2 | 2017 | 2631 | 0.140 |
Why?
|
HMGB1 Protein | 1 | 2018 | 141 | 0.140 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 615 | 0.140 |
Why?
|
Syndecan-4 | 1 | 2016 | 45 | 0.140 |
Why?
|
Interleukin-4 | 2 | 2017 | 1156 | 0.140 |
Why?
|
Chemokine CCL5 | 1 | 2017 | 214 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 837 | 0.130 |
Why?
|
Pemphigoid, Bullous | 1 | 2018 | 110 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2023 | 11878 | 0.130 |
Why?
|
HTLV-I Infections | 1 | 2016 | 104 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2017 | 3514 | 0.130 |
Why?
|
Thyroiditis | 1 | 2016 | 86 | 0.130 |
Why?
|
Biopsy | 5 | 2019 | 6793 | 0.130 |
Why?
|
Chemokine CX3CL1 | 1 | 2016 | 62 | 0.130 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 306 | 0.130 |
Why?
|
Humans | 49 | 2025 | 768166 | 0.130 |
Why?
|
Cell Proliferation | 6 | 2021 | 10474 | 0.130 |
Why?
|
Drug Eruptions | 1 | 2018 | 335 | 0.130 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2016 | 168 | 0.120 |
Why?
|
Vitiligo | 1 | 2016 | 97 | 0.120 |
Why?
|
Stomatitis | 1 | 2018 | 271 | 0.120 |
Why?
|
Azepines | 1 | 2017 | 329 | 0.120 |
Why?
|
Receptors, IgG | 1 | 2018 | 564 | 0.120 |
Why?
|
Scleroderma, Localized | 1 | 2015 | 85 | 0.120 |
Why?
|
Japan | 2 | 2016 | 1418 | 0.120 |
Why?
|
Vascular System Injuries | 1 | 2018 | 248 | 0.120 |
Why?
|
Male | 28 | 2021 | 364719 | 0.110 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 749 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2954 | 0.110 |
Why?
|
Proteoglycans | 1 | 2017 | 809 | 0.110 |
Why?
|
Interleukin-1 | 1 | 2018 | 1252 | 0.110 |
Why?
|
Chemotaxis | 1 | 2017 | 600 | 0.110 |
Why?
|
Alopecia Areata | 1 | 2016 | 130 | 0.110 |
Why?
|
Macrophages | 3 | 2018 | 5799 | 0.110 |
Why?
|
Homeostasis | 1 | 2024 | 3348 | 0.110 |
Why?
|
Interferon-alpha | 1 | 2017 | 910 | 0.110 |
Why?
|
Receptors, Virus | 1 | 2017 | 652 | 0.110 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1327 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8647 | 0.110 |
Why?
|
Th17 Cells | 1 | 2019 | 791 | 0.100 |
Why?
|
Receptors, Chemokine | 1 | 2016 | 652 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1640 | 0.100 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.100 |
Why?
|
Tumor Escape | 1 | 2015 | 372 | 0.100 |
Why?
|
Mice | 9 | 2025 | 82029 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2025 | 4058 | 0.100 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 617 | 0.100 |
Why?
|
Melanoma, Experimental | 1 | 2015 | 559 | 0.100 |
Why?
|
Female | 27 | 2024 | 397192 | 0.100 |
Why?
|
Immunotherapy | 2 | 2025 | 4755 | 0.100 |
Why?
|
Disease Progression | 5 | 2019 | 13671 | 0.100 |
Why?
|
Triazoles | 1 | 2017 | 904 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2017 | 924 | 0.090 |
Why?
|
Brazil | 1 | 2015 | 1250 | 0.090 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1561 | 0.090 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 3948 | 0.090 |
Why?
|
Aged | 16 | 2023 | 171504 | 0.090 |
Why?
|
Animals | 13 | 2025 | 169246 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4030 | 0.090 |
Why?
|
Colon | 1 | 2018 | 1801 | 0.080 |
Why?
|
Colonoscopy | 1 | 2018 | 1409 | 0.080 |
Why?
|
Antigen Presentation | 1 | 2015 | 1251 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4648 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 810 | 0.080 |
Why?
|
Oxazolone | 2 | 2019 | 61 | 0.080 |
Why?
|
Fatal Outcome | 2 | 2017 | 1836 | 0.080 |
Why?
|
Adult | 16 | 2019 | 223646 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2020 | 11095 | 0.080 |
Why?
|
Severity of Illness Index | 7 | 2021 | 15948 | 0.080 |
Why?
|
Young Adult | 7 | 2019 | 60066 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 2 | 2018 | 564 | 0.070 |
Why?
|
Lymphoma | 1 | 2015 | 1898 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22379 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13014 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10266 | 0.060 |
Why?
|
Betapapillomavirus | 1 | 2024 | 15 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3603 | 0.060 |
Why?
|
Cell Line, Tumor | 5 | 2019 | 17140 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5706 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6009 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2015 | 3474 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 30010 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2020 | 7876 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2023 | 6974 | 0.050 |
Why?
|
Drug Combinations | 1 | 2009 | 2089 | 0.050 |
Why?
|
Cells, Cultured | 1 | 2017 | 19015 | 0.050 |
Why?
|
Down-Regulation | 2 | 2021 | 2937 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18349 | 0.050 |
Why?
|
Mice, Transgenic | 3 | 2021 | 9561 | 0.050 |
Why?
|
Tetrahydronaphthalenes | 1 | 2021 | 85 | 0.040 |
Why?
|
Chemotactic Factors | 1 | 2021 | 197 | 0.040 |
Why?
|
Genes, T-Cell Receptor gamma | 1 | 2020 | 16 | 0.040 |
Why?
|
Pyrimidinones | 1 | 2023 | 386 | 0.040 |
Why?
|
Tumor Burden | 2 | 2017 | 1906 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13676 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 637 | 0.040 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2024 | 329 | 0.040 |
Why?
|
Receptors, CCR10 | 1 | 2019 | 10 | 0.040 |
Why?
|
Croton Oil | 1 | 2019 | 3 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1103 | 0.040 |
Why?
|
Water Loss, Insensible | 1 | 2019 | 12 | 0.040 |
Why?
|
Desmosomes | 1 | 2019 | 73 | 0.040 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2021 | 293 | 0.040 |
Why?
|
beta-Defensins | 1 | 2018 | 60 | 0.040 |
Why?
|
Carcinoma, Basal Cell | 1 | 2024 | 565 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4415 | 0.040 |
Why?
|
Papillomaviridae | 1 | 2024 | 1140 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 753 | 0.040 |
Why?
|
Phosphorylation | 2 | 2019 | 8317 | 0.040 |
Why?
|
Calgranulin A | 1 | 2018 | 81 | 0.040 |
Why?
|
Skin Diseases, Infectious | 1 | 2018 | 75 | 0.040 |
Why?
|
Ultraviolet Therapy | 1 | 2018 | 82 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2019 | 240 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2019 | 14488 | 0.040 |
Why?
|
HLA Antigens | 1 | 2023 | 1334 | 0.040 |
Why?
|
Neoadjuvant Therapy | 1 | 2009 | 2907 | 0.040 |
Why?
|
Pyridones | 1 | 2023 | 819 | 0.040 |
Why?
|
Growth Substances | 1 | 2019 | 759 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2019 | 687 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2018 | 412 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 719 | 0.030 |
Why?
|
Cell Movement | 2 | 2019 | 5210 | 0.030 |
Why?
|
Leucovorin | 1 | 2018 | 643 | 0.030 |
Why?
|
Caspases | 1 | 2019 | 882 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2017 | 514 | 0.030 |
Why?
|
Blotting, Southern | 1 | 2016 | 775 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2018 | 794 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1801 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2017 | 334 | 0.030 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2018 | 221 | 0.030 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 268 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 258 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2017 | 9118 | 0.030 |
Why?
|
Arm | 1 | 2018 | 591 | 0.030 |
Why?
|
Gastroscopy | 1 | 2017 | 213 | 0.030 |
Why?
|
Camptothecin | 1 | 2018 | 600 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2020 | 1864 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1003 | 0.030 |
Why?
|
Nose | 1 | 2018 | 522 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1609 | 0.030 |
Why?
|
Cell Line | 2 | 2019 | 15597 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2016 | 390 | 0.030 |
Why?
|
Endothelial Cells | 2 | 2017 | 3589 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2019 | 998 | 0.030 |
Why?
|
Eosinophils | 1 | 2018 | 952 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2018 | 1622 | 0.030 |
Why?
|
Cyclins | 1 | 2015 | 606 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2059 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2018 | 1082 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2862 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2015 | 825 | 0.030 |
Why?
|
Scalp | 1 | 2015 | 391 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 89169 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2627 | 0.020 |
Why?
|
Cell Count | 1 | 2016 | 1832 | 0.020 |
Why?
|
Neoplasms | 1 | 2021 | 22371 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3814 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4938 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 1430 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20760 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2018 | 3620 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 1613 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 2048 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4580 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6514 | 0.020 |
Why?
|
Mutation | 2 | 2024 | 30238 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2167 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3611 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1890 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1802 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6526 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2211 | 0.020 |
Why?
|
Mast Cells | 1 | 2015 | 1406 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4035 | 0.020 |
Why?
|
Viral Load | 1 | 2016 | 3396 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2541 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2015 | 81762 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5902 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1892 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5703 | 0.020 |
Why?
|
Survival Analysis | 1 | 2018 | 10101 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3445 | 0.020 |
Why?
|
Lung Neoplasms | 2 | 2021 | 13586 | 0.020 |
Why?
|
Signal Transduction | 2 | 2019 | 23645 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3833 | 0.010 |
Why?
|
Models, Biological | 1 | 2021 | 9495 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4352 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40218 | 0.010 |
Why?
|
DNA Methylation | 1 | 2018 | 4428 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8509 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5804 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21538 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10873 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6669 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16726 | 0.010 |
Why?
|
Apoptosis | 1 | 2017 | 9523 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36743 | 0.010 |
Why?
|
Transcription Factors | 1 | 2017 | 12168 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 65371 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 59629 | 0.010 |
Why?
|